Feng Luo

2.4k total citations
36 papers, 1.3k citations indexed

About

Feng Luo is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Feng Luo has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Feng Luo's work include Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Feng Luo is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Feng Luo collaborates with scholars based in United States, China and Germany. Feng Luo's co-authors include Stephen G. Chaney, Steven D. Wyrick, Jinbang Li, Jean Lu, Kunping Liu, Ailan Guo, Patrick J. Sinko, Wenxin Zheng, Eric H. Rubin and Anne Blackwood‐Chirchir and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Feng Luo

36 papers receiving 1.3k citations

Peers

Feng Luo
Magdalena Winiarska Poland
Eleanor G. Zuhowski United States
Krishna Menon United States
Douglas C. Marchion United States
Fernando Doñate United States
Kathleen D. Whitney United States
Shelley M. Herbrich United States
Jon Rosen United States
Jean-Louis Misset France
Vito Barbieri Italy
Magdalena Winiarska Poland
Feng Luo
Citations per year, relative to Feng Luo Feng Luo (= 1×) peers Magdalena Winiarska

Countries citing papers authored by Feng Luo

Since Specialization
Citations

This map shows the geographic impact of Feng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Luo more than expected).

Fields of papers citing papers by Feng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Luo. The network helps show where Feng Luo may publish in the future.

Co-authorship network of co-authors of Feng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Luo. A scholar is included among the top collaborators of Feng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Luo. Feng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Jiewei, et al.. (2021). MDT Treatment of Small Cell Lung Cancer Complicated with Adenocarcinoma: 
A Case Report and Literature Review. SHILAP Revista de lepidopterología. 2 indexed citations
3.
Chen, Lu, Chao Li, Rui Huang, et al.. (2020). The multifaceted roles of long noncoding RNAs in pancreatic cancer: an update on what we know. Cancer Cell International. 20(1). 41–41. 23 indexed citations
4.
5.
Liu, Kunping, et al.. (2017). GSK-3β inhibitor 6-bromo-indirubin-3′-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells. International Journal of Oncology. 51(6). 1821–1830. 17 indexed citations
6.
Luo, Feng, et al.. (2016). Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway. International Journal of Oncology. 48(4). 1333–1340. 88 indexed citations
7.
8.
Luo, Feng, Nathan R. Rustay, Terese Seifert, et al.. (2010). Magnetic Resonance Imaging Detection and Time Course of Cerebral Microhemorrhages during Passive Immunotherapy in Living Amyloid Precursor Protein Transgenic Mice. Journal of Pharmacology and Experimental Therapeutics. 335(3). 580–588. 22 indexed citations
9.
Eley, Timothy, Feng Luo, Shruti Agrawal, et al.. (2009). Phase I Study of the Effect of Gastric Acid pH Modulators on the Bioavailability of Oral Dasatinib in Healthy Subjects. The Journal of Clinical Pharmacology. 49(6). 700–709. 85 indexed citations
10.
Luo, Feng, Terese Seifert, Rohinton Edalji, et al.. (2008). Non-invasive characterization of β-amyloid1-40 vasoactivity by functional magnetic resonance imaging in mice. Neuroscience. 155(1). 263–269. 19 indexed citations
11.
Wong, Tai W., Francis Y. Lee, Chiang Yu, et al.. (2006). Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling. Clinical Cancer Research. 12(20). 6186–6193. 65 indexed citations
12.
Luo, Feng, Zheng Yang, Amy Camuso, et al.. (2005). Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft. Cancer Chemotherapy and Pharmacology. 56(5). 455–464. 66 indexed citations
13.
Lalloo, Anita, Feng Luo, Ailan Guo, et al.. (2004). Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2). BMC Medicine. 2(1). 16–16. 54 indexed citations
14.
Luo, Feng, et al.. (2002). Intestinal Transport of Irinotecan in Caco-2 Cells and MDCK II Cells Overexpressing Efflux Transporters Pgp, cMOAT, and MRP1. Drug Metabolism and Disposition. 30(7). 763–770. 86 indexed citations
15.
Wang, Jun, Feng Luo, Jean Lu, et al.. (2001). VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors. International Journal of Cancer. 97(2). 163–167. 49 indexed citations
16.
Lu, Jean, et al.. (2000). Tumor Stroma as the Main Source of Inhibin Production in Ovarian Epithelial Tumors. American Journal of Reproductive Immunology. 44(2). 104–113. 15 indexed citations
17.
Luo, Feng, Ten‐Yang Yen, Steven D. Wyrick, & Stephen G. Chaney. (1999). High-performance liquid chromatographic separation of the biotransformation products of oxaliplatin. Journal of Chromatography B Biomedical Sciences and Applications. 724(2). 345–356. 41 indexed citations
18.
Luo, Feng, Steven D. Wyrick, & Stephen G. Chaney. (1999). Biotransformations of oxaliplatin in rat blood in vitro. Journal of Biochemical and Molecular Toxicology. 13(3-4). 159–169. 38 indexed citations
19.
Luo, Feng, Steven D. Wyrick, & Stephen G. Chaney. (1999). Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture model. Cancer Chemotherapy and Pharmacology. 44(1). 29–38. 56 indexed citations
20.
Luo, Feng, Steven D. Wyrick, & Stephen G. Chaney. (1999). Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats. Cancer Chemotherapy and Pharmacology. 44(1). 19–28. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magdalena Winiarska Breakdown of academic impact, for papers by Eleanor G. Zuhowski Breakdown of academic impact, for papers by Krishna Menon Breakdown of academic impact, for papers by Douglas C. Marchion Breakdown of academic impact, for papers by Fernando Doñate Breakdown of academic impact, for papers by Kathleen D. Whitney Breakdown of academic impact, for papers by Shelley M. Herbrich Breakdown of academic impact, for papers by Jon Rosen Breakdown of academic impact, for papers by Jean-Louis Misset Breakdown of academic impact, for papers by Vito Barbieri
Rankless by CCL
2026